High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one <a target=_blank href= ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

The vector control market is experiencing strong growth ... Inc. today presented the first in-depth look at full results from ...

“Execution of our ongoing upliFT-D trial for FTD-GRN remains our core priority ... The presentation reviewed the robust preclinical findings informing vector and dose selection and demonstrated the ...

NGN-401 uses an adeno-associated virus serotype 9 vector to deliver a full-length functional MECP2 gene using the firm's EXACT transgene regulation technology. NGN-401 is under evaluation in the FDA's ...

Diamond-Blackfan anemia (DBA) is a potentially life-threatening condition that can cause severe anemia and other abnormalities. It's a rare genetic blood disorder that occurs when the bone marrow ...

NGGT has initiated Phase I/II clinical trials in the U.S. and China to evaluate the safety and efficacy of NGGT002 for the treatment of Phenylketonuria ...

This clinical-grade vector is ready, and the team hopes to take it to clinical trial next.Vijay Sankaran, MD, PhD, lead and ...

This clinical-grade vector is ready, and the team hopes to take it to clinical trial next.Vijay Sankaran, MD, PhD, lead and corresponding author of the paper, is available for comment if you’re ...

Senior officials from the US Navy and Japan Maritime Self-Defense Force joined the crew of the JS Kaga, as F-35B pilots from ...